Literature DB >> 17484802

Modulation of HLA expression in human cytomegalovirus immune evasion.

Aifen Lin1, Huihui Xu, Weihua Yan.   

Abstract

Human cytomegalovirus (hCMV) has evolved multiple mechanisms to escape the host immune recognition and innate or adaptive immune responses. Among them, hCMV has developed strategies to modulate the expression and/or function of human leukocyte antigens (HLAs), including by encoding series of infection stage-dependent hCMV proteins to detain and destroy the expression of HLA molecules on the surface of infected cells. This disturbs the antigen presentation and processing, by encoding MHC class I homologues or selective up-regulation of particular HLA class I molecules binding to NK cell inhibitory receptors, and by encoding specific ligand antagonists to interfere with NK cell activating receptors. Here we discussed the molecular mechanisms utilized by the hCMV to alter the formation, transportation and expression of HLA antigens on the infected cell surface. The knowledge about hCMV modulating HLA expression could benefit us to further understand the pathogenesis of viral diseases and may eventually develop novel effective immunotherapies to counteract viral infections and viral associated diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484802

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  27 in total

Review 1.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

2.  Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells.

Authors:  M Zeeshan Chaudhry; Rosaely Casalegno-Garduno; Katarzyna M Sitnik; Bahram Kasmapour; Ann-Kathrin Pulm; Ilija Brizic; Britta Eiz-Vesper; Andreas Moosmann; Stipan Jonjic; Edward S Mocarski; Luka Cicin-Sain
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-22       Impact factor: 11.205

3.  Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.

Authors:  Guenther Koehne; Aisha Hasan; Ekaterina Doubrovina; Susan Prockop; Eleanor Tyler; Gloria Wasilewski; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-29       Impact factor: 5.742

Review 4.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 5.  Multifaceted evasion of the interferon response by cytomegalovirus.

Authors:  Emily E Marshall; Adam P Geballe
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

6.  Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71.

Authors:  Xiao-Qun Zheng; Xiao-Qing Chen; Yan Gao; Miao Fu; Yi-Ping Chen; Dan-Ping Xu; Aifen Lin; Wei-Hua Yan
Journal:  Clin Exp Med       Date:  2013-04-21       Impact factor: 3.984

7.  Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules.

Authors:  Kristina Oresic; Domenico Tortorella
Journal:  J Gen Virol       Date:  2008-05       Impact factor: 3.891

8.  Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

Authors:  Luka Cicin-Sain; Ivan Bubić; Margit Schnee; Zsolt Ruzsics; Christian Mohr; Stipan Jonjić; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.

Authors:  J Altomonte; L Wu; M Meseck; L Chen; O Ebert; A Garcia-Sastre; J Fallon; J Mandeli; S L C Woo
Journal:  Cancer Gene Ther       Date:  2008-10-10       Impact factor: 5.987

Review 10.  The Yin and Yang of HLA and KIR in human disease.

Authors:  Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal:  Semin Immunol       Date:  2008-07-16       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.